Abstract:Abstract. To develop diabetes risk score (RS) based on the current definition of diabetes, we retrospectively analyzed consecutive 4,159 health examinees who were non-diabetic at baseline. Diabetes, diagnosed by fasting plasma glucose (FPG) ≥7.0 mmol/L, 2hPG ≥11.1 mmol/L and/or HbA1c ≥6.5% (48 mmol/mol), developed in 279 of them during the mean period of 4.9 years. A full RS (RS Full ), a RS without 2hPG (RS -2hPG ) and a non-invasive RS (RS NI ) were created on the basis of multivariate Cox proportional model… Show more
“…The non‐invasive prediction model showed fair predictive ability, with an AUROC of 0.73, which was within the reported range based on previous studies carried out in Japan (AUROC ranged between 0.68 and 0.77) and other countries (AUROC ranged between 0.62 and 0.87). As expected, our invasive model including both HbA1c and FPG showed a convincing performance for predicting diabetes.…”
Section: Discussionsupporting
confidence: 86%
“…However, these risk models might not be applied to external populations, particularly if ethnicities and countries differ from the derivation populations. In Japan, a few risk models have been developed using data from health checkups at hospital or local community settings. Among these, some were developed utilizing a small sample ( n < 2,000), and excluded individuals aged >40 years.…”
Section: Introductionmentioning
confidence: 99%
“…Among these, some were developed utilizing a small sample ( n < 2,000), and excluded individuals aged >40 years. Furthermore, some models included variables that were not routinely collected at regular health checkups (e.g., family health history and exercise), limiting the wider use of these prediction tools.…”
Aims/IntroductionWe previously developed a 3‐year diabetes risk score in the working population. The objective of the present study was to develop and validate flexible risk models that can predict the risk of diabetes for any arbitrary time‐point during 7 years.Materials and MethodsThe participants were 46,198 Japanese employees aged 30–59 years, without diabetes at baseline and with a maximum follow‐up period of 8 years. Incident diabetes was defined according to the American Diabetes Association criteria. With routine health checkup data (age, sex, abdominal obesity, body mass index, smoking status, hypertension status, dyslipidemia, glycated hemoglobin and fasting plasma glucose), we developed non‐invasive and invasive risk models based on the Cox proportional hazards regression model among a random two‐thirds of the participants, and used another one‐third for validation.ResultsThe range of the area under the receiver operating characteristic curve increased from 0.73 (95% confidence interval 0.72–0.74) for the non‐invasive prediction model to 0.89 (95% confidence interval 0.89–0.90) for the invasive prediction model containing dyslipidemia, glycated hemoglobin and fasting plasma glucose. The invasive models showed improved integrated discrimination and reclassification performance, as compared with the non‐invasive model. Calibration appeared good between the predicted and observed risks. These models performed well in the validation cohort.ConclusionsThe present non‐invasive and invasive models for the prediction of diabetes risk up to 7 years showed fair and excellent performance, respectively. The invasive models can be used to identify high‐risk individuals, who would benefit greatly from lifestyle modification for the prevention or delay of diabetes.
“…The non‐invasive prediction model showed fair predictive ability, with an AUROC of 0.73, which was within the reported range based on previous studies carried out in Japan (AUROC ranged between 0.68 and 0.77) and other countries (AUROC ranged between 0.62 and 0.87). As expected, our invasive model including both HbA1c and FPG showed a convincing performance for predicting diabetes.…”
Section: Discussionsupporting
confidence: 86%
“…However, these risk models might not be applied to external populations, particularly if ethnicities and countries differ from the derivation populations. In Japan, a few risk models have been developed using data from health checkups at hospital or local community settings. Among these, some were developed utilizing a small sample ( n < 2,000), and excluded individuals aged >40 years.…”
Section: Introductionmentioning
confidence: 99%
“…Among these, some were developed utilizing a small sample ( n < 2,000), and excluded individuals aged >40 years. Furthermore, some models included variables that were not routinely collected at regular health checkups (e.g., family health history and exercise), limiting the wider use of these prediction tools.…”
Aims/IntroductionWe previously developed a 3‐year diabetes risk score in the working population. The objective of the present study was to develop and validate flexible risk models that can predict the risk of diabetes for any arbitrary time‐point during 7 years.Materials and MethodsThe participants were 46,198 Japanese employees aged 30–59 years, without diabetes at baseline and with a maximum follow‐up period of 8 years. Incident diabetes was defined according to the American Diabetes Association criteria. With routine health checkup data (age, sex, abdominal obesity, body mass index, smoking status, hypertension status, dyslipidemia, glycated hemoglobin and fasting plasma glucose), we developed non‐invasive and invasive risk models based on the Cox proportional hazards regression model among a random two‐thirds of the participants, and used another one‐third for validation.ResultsThe range of the area under the receiver operating characteristic curve increased from 0.73 (95% confidence interval 0.72–0.74) for the non‐invasive prediction model to 0.89 (95% confidence interval 0.89–0.90) for the invasive prediction model containing dyslipidemia, glycated hemoglobin and fasting plasma glucose. The invasive models showed improved integrated discrimination and reclassification performance, as compared with the non‐invasive model. Calibration appeared good between the predicted and observed risks. These models performed well in the validation cohort.ConclusionsThe present non‐invasive and invasive models for the prediction of diabetes risk up to 7 years showed fair and excellent performance, respectively. The invasive models can be used to identify high‐risk individuals, who would benefit greatly from lifestyle modification for the prevention or delay of diabetes.
“…A cost‐effective approach is needed to achieve T2D prevention in routine primary care and the general population. Family histories of T2D, metabolic syndrome (MetS), and nonalcoholic fatty liver disease (NAFLD) are also associated with an increased risk of T2D . It is unclear whether MetS and NAFLD are associated with an increased risk of T2D.…”
Section: Question 4: What Additional Research Is Needed In a Real‐wormentioning
confidence: 99%
“…Family histories of T2D, metabolic syndrome (MetS), and nonalcoholic fatty liver disease (NAFLD) are also associated with an increased risk of T2D. [38][39][40] It is unclear whether MetS and NAFLD are associated with an increased risk of T2D. From the point of view of a cost-effective approach, possible target population and target values are summarized in Table 5.…”
Section: Question 4: What Additional Research Is Needed In a Real-wmentioning
Type 2 diabetes (T2D) is associated with increased risks of morbidity and mortality. Diabetes prevention is an urgent issue in Japan. The Finnish Diabetes Prevention Study and US Diabetes Prevention Program revealed that intensive lifestyle intervention can prevent or delay the development of T2D in high‐risk populations. Translational research varies in hospitals, primary care, communities, the workplace, and other settings. Translational research is feasible but less effective. There have been no long‐term follow‐ups. The outcome of the studies was mainly weight changes. The Japan Diabetes Prevention Program (JDPP) is a trial to test the efficacy of a lifestyle intervention program, which carried out in a primary healthcare setting using existing resources. The Japan Diabetes Outcome Trial‐1 (J‐DOIT1) is a nationwide telephone‐delivered lifestyle intervention in a real‐world setting. This review will focus on the effectiveness of a diabetes prevention program (recruitment, target population, method of intervention, and evaluation) in the real world and insights from the JDPP and J‐DOIT1.
Background
Risk prediction models can help identify individuals at high risk for type 2 diabetes. However, no such model has been applied to clinical practice in eastern China.
Aims
This study aims to develop a simple model based on physical examination data that can identify high-risk groups for type 2 diabetes in eastern China for predictive, preventive, and personalized medicine.
Methods
A 14-year retrospective cohort study of 15,166 nondiabetic patients (12–94 years; 37% females) undergoing annual physical examinations was conducted. Multivariate logistic regression and least absolute shrinkage and selection operator (LASSO) models were constructed for univariate analysis, factor selection, and predictive model building. Calibration curves and receiver operating characteristic (ROC) curves were used to assess the calibration and prediction accuracy of the nomogram, and decision curve analysis (DCA) was used to assess its clinical validity.
Results
The 14-year incidence of type 2 diabetes in this study was 4.1%. This study developed a nomogram that predicts the risk of type 2 diabetes. The calibration curve shows that the nomogram has good calibration ability, and in internal validation, the area under ROC curve (AUC) showed statistical accuracy (AUC = 0.865). Finally, DCA supports the clinical predictive value of this nomogram.
Conclusion
This nomogram can serve as a simple, economical, and widely scalable tool to predict individualized risk of type 2 diabetes in eastern China. Successful identification and intervention of high-risk individuals at an early stage can help to provide more effective treatment strategies from the perspectives of predictive, preventive, and personalized medicine.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.